Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.

Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses.
复制标题

DOI:
10.1016/j.cell.2021.11.007
复制
发表时间:
2021-12-09
期刊:
影响因子:
64.5
通讯作者:
Joshi NS
Joshi NS
中科院分区:
生物学1区
文献类型:
--
作者:
Cui C;Wang J;Fagerberg E;Chen PM;Connolly KA;Damo M;Cheung JF;Mao T;Askari AS;Chen S;Fitzgerald B;Foster GG;Eisenbarth SC;Zhao H;Craft J;Joshi NS

文献摘要

参考文献

被引文献

相似文献

CD4 T滤泡辅助细胞(TFH)支持B细胞,这对生发中心(GC)的形成至关重要,但TFH-B细胞相互作用在癌症中的重要性尚不清楚。我们发现,在肺腺癌(LUAD)患者中,TFH细胞转录特征的富集与GC B细胞特征和延长生存期相关。我们进一步建立了小鼠LUAD模型,其中肿瘤细胞表达b细胞和t细胞识别的新抗原。肿瘤特异性TFH和GC B细胞之间的相互作用,以及主要由TFH细胞产生的IL-21,是肿瘤控制和CD8 T细胞功能的必要条件。TFH细胞的发育需要B细胞和B细胞识别的新抗原。因此,肿瘤新抗原可以通过促进肿瘤特异性CD4 T细胞与肿瘤特异性B细胞的相互作用来调节肿瘤特异性CD4 T细胞的命运,从而通过增强CD8 T细胞效应功能来促进抗肿瘤免疫。生发中心B细胞以新抗原依赖的方式促进肿瘤特异性CD4 T滤泡辅助细胞的发展,进而通过产生IL-21增强CD8 T细胞效应功能,并在小鼠肺腺癌模型中驱动抗肿瘤免疫。
CD4 T follicular helper (TFH) cells support B cells, which is critical for germinal center (GC) formation, but the importance of TFH-B cell interactions in cancer is unclear. We found enrichment of TFH cell transcriptional signature correlates with GC B cell signature and with prolonged survival in patients with lung adenocarcinoma (LUAD). We further developed a murine LUAD model in which tumor cells express B-cell- and T-cell-recognized neoantigens. Interactions between tumor-specific TFH and GC B cells, as well as IL-21 primarily produced by TFH cells, are necessary for tumor control and effector CD8 T cell function. Development of TFH cells requires B cells and B-cell-recognized neoantigens. Thus, tumor neoantigens can regulate the fate of tumor-specific CD4 T cells by facilitating their interactions with tumor-specific B cells, which in turn promote anti-tumor immunity by enhancing CD8 T cell effector functions. Germinal center B cells promote the development of tumor-specific CD4 T follicular helper cells in a neoantigen-dependent manner, which in turn enhance CD8 T cell effector functions by producing IL-21 and drive anti-tumor immunity in a murine model of lung adenocarcinoma.
DOI: 10.1126/science.aao3859
发表时间: 2018-04-13
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Burnett DL;Langley DB;Schofield P;Hermes JR;Chan TD;Jackson J;Bourne K;Reed JH;Patterson K;Porebski BT;Brink R;Christ D;Goodnow CC
通讯作者: Goodnow CC
DOI: 10.1016/j.immuni.2011.03.023
发表时间: 2011-06-24
期刊: Immunity
影响因子: 32.4
作者:
Choi YS;Kageyama R;Eto D;Escobar TC;Johnston RJ;Monticelli L;Lao C;Crotty S
通讯作者: Crotty S
DOI: 10.1038/s41587-020-0613-1
发表时间: 2021-01
影响因子: 46.9
作者:
Damo M;Fitzgerald B;Lu Y;Nader M;William I;Cheung JF;Connolly KA;Foster GG;Akama-Garren E;Lee DY;Chang GP;Gocheva V;Schmidt LM;Boileve A;Wilson JH;Cui C;Monroy I;Gokare P;Cabeceiras P;Jacks T;Joshi NS
通讯作者: Joshi NS
DOI: 10.1038/s41586-019-1914-8
发表时间: 2020-01-01
期刊: NATURE
影响因子: 64.8
作者:
Cabrita, Rita;Lauss, Martin;Jonsson, Goran
通讯作者: Jonsson, Goran
DOI: 10.1038/srep16836
发表时间: 2016-02-18
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者:
Akama-Garren, Elliot H.;Joshi, Nikhil S.;Jacks, Tyler
通讯作者: Jacks, Tyler